Medivolve Announces Telehealth Platform Development Contract and Change of Officers and Directors

Medivolve Inc. (“

Medivolve

” or the “

Company

”) (NEO: MEDV; OTC: MEDVF; FRA:4NC) is pleased to announce that it has entered into a master services agreement dated December 29, 2023, with Engineer.ai Corp. (dba Builder.ai) (“

Builder

”) to assist in the development of its telehealth platform. Pursuant to the agreement, Builder will develop robust features of the platform, including but not limited to, provider and patient interfacing, telehealth video conferencing, appointment scheduling and management tools, credit card payment processing and more. Features of the platform aim to additionally integrate through Company API interfaces and third-party API interfaces, all in compliance with HIPAA (Health Insurance Portability and Accountability Act). The Company anticipates that development of the telehealth platform will be substantially complete within seven months.

Additionally, the Company announces today that Aaron Atin, Daniyal Baizak and Peter Michel have resigned from their positions as corporate secretary, director and chief financial officer of the Company, respectively, effective January 10, 2024, January 12, 2024 and January 15, 2024. Mr. Atin will continue to support the Company in his capacity as a consultant. The board and management thank Messrs. Atin, Baizak, and Michel for their services and contributions and wish them well in their future endeavours.

About Medivolve

Medivolve is a Canadian healthcare technology company headquartered in Toronto, Canada. The Company’s mission is to improve health and lives by delivering world-class diagnostic solutions—starting with COVID-19—as well as to enable faster and better care to patients through innovative technology. Medivolve, through its subsidiaries, operates retail patient-care locations in California.

For investing inquiries, please contact: David Preiner, CEO, [e-mail], 702-990-3737.

Cautionary Note Regarding Forward-looking Information

This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation. Forward-looking information includes, but is not limited to, statements with respect to the development of the telehealth platform, including its features and timeline to completion. Generally, forward-looking information can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will be taken", "occur" or "be achieved". Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company, as the case may be, to be materially different from those expressed or implied by such forward-looking information, including (but not limited to): uncertainties relating to the demand for a telehealth platform; the Company’s and Builder’s ability to develop the telehealth platform; risks inherent to the technological industry, including the emergence of disruptive technologies that may impact the demand for the telehealth platform; receipt of necessary approvals; general business, economic, competitive, political and social uncertainties; accidents, labour disputes and shortages and other risks of the healthcare and medical-related industries, and the other risk factors discussed in the Company’s most recent annual information form and management’s discussion and analysis, available on SEDAR+ at www.sedarplus.ca. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. The Company does not undertake to update any forward-looking information, except in accordance with applicable securities laws.